AstraZeneca PLC is 42.3x more valuable than Grifols SA by market capitalization ($286.27 B vs $6.77 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GRFS | AZN |
|---|---|---|
| Market cap | $6.77 B | $286.27 B |
| US-listed rank | #1183 | #45 |
| SEC filings | 457 | 1,004 |
AstraZeneca PLC is 42.3x more valuable than Grifols SA by market capitalization ($286.27 B vs $6.77 B).
Full pages: Grifols SA and AstraZeneca PLC, or browse the full rankings.